Skip to main content
Tanja Gruber, MD, Pediatric Hematology & Oncology, Palo Alto, CA, Lucile Packard Children's Hospital Stanford

TanjaAndreaGruberMDPhD

Pediatric Hematology & Oncology Palo Alto, CA

Pediatric Hematologic Oncology

Chief Pediatric Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Lucile Packard Children's Hospital

Dr. Gruber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gruber's full profile

Already have an account?

Education & Training

  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2006 - 2009
  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesResidency, Pediatrics, 2003 - 2006
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2020 - 2024
  • TN State Medical License
    TN State Medical License 2009 - 2021
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prognostic Impact of T(16;21)(p11;q22) and T(16;21)(q24;q22) in Pediatric AML: A Retrospective Study by the I-BFM Study Group  
    Soheil Meshinchi, Tanja A Gruber, Blood

Abstracts/Posters

  • KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia Cells Undergo ER-Stress-Induced Apoptosis Following Exposure to Proteasome Inhibitors
    Tanja A. Gruber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A 5-Gene Ara-C, Daunorubicin and Etoposide (ADE) Drug Response Score As a Prognostic Tool to Predict AML Treatment Outcome
    Tanja A. Gruber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome
    Tanja A. Gruber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • 8 Oncologists on the Move
    8 Oncologists on the MoveAugust 26th, 2020
  • Stanford Children's Health Appoints New Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine
    Stanford Children's Health Appoints New Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation, and Regenerative MedicineAugust 20th, 2020
  • Dr. Tanja Gruber Named Director of Stanford Children's Center for Childhood Cancer, Blood Diseases
    Dr. Tanja Gruber Named Director of Stanford Children's Center for Childhood Cancer, Blood DiseasesAugust 20th, 2020
  • Join now to see all

Hospital Affiliations